Novo Nordisk

Weight-Loss Drug Price Wars Are Upending Big Pharma’s Business Model

Prices for popular GLP-1 weight-loss drugs are falling rapidly, pressuring pharmaceutical companies to overhaul pricing strategies and rethink long-term business…

2 weeks ago

This website uses cookies.